A wandering Ozurdex in the anterior chamber
Dexamethasone intravitreal implantation (Ozurdex®, Allergan Inc. Irvine, CA, USA) has been used in the treatment of persistent macular edema (ME) due to various vitreoretinal diseases. We described a case of Ozurdex® migration into the anterior chamber. This patient had diabetes mellitus for years a...
Saved in:
| Main Authors: | Ching-Tai Chen, Shih-Chun Chao, Hung-Yu Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Taiwan Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/tjo.TJO-D-23-00013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Subconjunctival dexamethasone implant (Ozurdex®) in the management of refractory Non-Infectious anterior scleritis
by: Battuya Ganbold, et al.
Published: (2025-05-01) -
Visual and Anatomical Outcome Of Ozurdex Implant In Non-Infectious Intermediate Or Posterior Uveitis In Treatment Naive Patients
by: Navneet Mehrotra, et al.
Published: (2018-04-01) -
Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema – a real-world scenario
by: Elder Ohara de Oliveira Júnior, et al.
Published: (2025-01-01) -
Efficacy of Intravitreal Dexamethasone Implant (Ozurdex<sup>®</sup>) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema
by: Panagiotis Stavrakas, et al.
Published: (2025-03-01) -
Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex®, for refractory diabetic macular oedema
by: Aya Refaat Ali Mohammed, et al.
Published: (2025-03-01)